Prognostic factors for progression of mitral regurgitation in patients with coronary heart disease after aortocoronary bypass surgery alone and in combination with surgical left ventricular reconstruction


AIM: To identify risk and prognostic factors for mitral regurgitation (MR) progression after aortocoronary bypass surgery (ACBS) alone and in combination with surgical left ventricular (LV) reconstruction/MATERIAL AND METHODS: Data on 101 patients with coronary heart disease who had undergone surgical treatment: ACBS alone in 57 (56%) patients and that in combination with surgical LV reconstruction in 44 (44%)/RESULTS: In the late periods after ACBS alone, there was reduced or no MR in 18% of the patients; no substantial changes in MR in 52%, the latter being moderate; progression to significant mitral insufficiency (MI) in 30%. In the same periods after ACBS in combination with surgical LV reconstruction, there was a reduction in MR to its minimum or complete absence in 14% of the patients; no substantial change in the degree of MR in 54%, and progression to significant MI in 32%. The prognostic factors of MI progression after ACBs alone and in combination with surgical LV reconstruction were a more than 32-mm fibrous ring of the mitral valve (MV) (χ2=11.62; р=0.0001); a LV sphericity index of more than 0.65 cm (χ2=3.38; р=0.06); a myocardial scar lesion extent of more than 30% of the LV segments (χ2=4.7; р=0.03); a myocardial reserve of less than 25% (χ2=3.1; р=0.07) (when taking low-dose dobutamine)/CONCLUSION: Myocardial revascularization should be combined with MV intervention in patients with moderate MR and risk factors for its progression, such as significant LV remodeling (LV sphericity index of more than 0.65 cm), extensive LV scar lesion (more than 30% of the segments), a low myocardial reserve (less than 25%) during dobutamine test, and a MV fibrous ring of more than 32 mm).

Full Text

Restricted Access

About the authors

Iu I Buziashvili

I V Koksheneva


E M Khutsurauli


É U Asymbekova

L S Shakhnazarian


S T Abukov


  1. Campwala S.Z., Bansal R.C., Wang N. et al. Mitral regurgitation progression following isolated coronary artery bypass surgery: frequency, risk factors, and potential prevention strategies. Eur J Cardiothorac Surg 2006; 29: 348-354.
  2. Filsoufi F., Parwis B., Rahmanian M.D. et al. Physiologic basis for the surgical treatment of ischemic mitral regurgitation. Am Heart Hosp J 2006; 4: 261-268.
  3. Суханов С.Г., Орехова Е.Н. Коррекция умеренной митральной регургитации в лечении сердечной недостаточности у больных с постинфарктной аневризмой сердца. Бюл НЦССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания 2007; 1: 37-41.
  4. Agricola E., Oppizzi M., Pisani M. et al. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr 2007; 9: 207-221.
  5. Бокерия Л.А., Скопин И.И., Мироненко В.А. Хирургическое лечение ишемической митральной недостаточности. М: Изд. НЦ ССХ им. А.Н. Бакулева РАМН 2003.
  6. Бурдули Т.В., Можина А.А., Мацкеплишвили С.Т. и др. Влияние ишемического ремоделирования левого желудочка на развитие митральной недостаточности у больных ИБС. Бюл НЦ ССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания 2005; 2: 103-112.
  7. Ключников И.В. Ишемическое ремоделирование левого желудочка в коронарной хирургии: Дис. ... д-ра мед. наук. М 2002.
  8. Alfier O. The Edge to Edge technique. Post graduate courses 14th Annual Meeting of the European Association for Cardio-thoracic Surgery. Frankfurt 2000: 25-27.
  9. Menicanti L., Di Donato M., Frigola A. Ishemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg 2002; 123: 1041-1050.
  10. Konstam M.A., Kronenberg M.W., Rousseau M.F. et al. Effects of the angiotensin converting enzyme inhibitors, enalapril, on the long term progression of left ventricular dilatation in patients with heart failure. SOLVD investigators. Circulations 1993; 88: 2277-2283.
  11. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101: 2981-2988.
  12. Sutton St. J., Pfeffer M.A., Moye L. et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Circulation 1997; 96: 3294-3299.
  13. Khattar R.S., Senior R., Soman P. et al. Regression of left ventricular remodeling in chronic heart failure: comparative and combined effects of captopril and carvedilol. Am Heart J 2001; 142: 704-713.
  14. Hall S.A., Cigarroa C.G., Marcoux L. et al. Time courceof improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta- adrenergic blockade. J Am Coll Cardlol 1995; 25: 1154-1161.
  15. Groenning B.A., Nilsson J.C., Sondergaard L. et al. Antiremodeling effects on the left ventricle during beta- blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000; 36: 2072-2080.
  16. Doughty R.N., Whalley G.A., Gamble G. et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997; 29: 1060-1066.
  17. Gilbert E.M., Abraham W.T., Olsen S. et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 1996; 94: 2617-2825.



Abstract - 24



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies